Entering text into the input field will update the search result below

Bellerophon Therapeutics reports Q1 results

  • Bellerophon Therapeutics (NASDAQ:BLPH): Q1 EPS of -$0.04
  • Press Release

Recommended For You

About BLPH Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BLPH--
Bellerophon Therapeutics, Inc.